Products, Services, Technologies

Rostra Therapeutics Ltd

Solution Type

Antimicrobial Compound

Pathogens Addressed

Bacteria, Fungi, Viruses, Yeasts, Parasites

Sectors Served

Human Health

Overview

Rostra Therapeutics is a London-based drug discovery company developing S-MGB (Sequence-selective Minor Groove Binding) molecules that kill bacteria, fungi, parasites, and viruses by binding simultaneously to multiple sites on DNA and RNA. This multi-target mechanism of action is inherently difficult for pathogens to evade through resistance, positioning S-MGBs as a potentially resilient platform for new anti-infective therapeutics.

Stay Updated

Stay connected so that you don't miss the latest AMR insights and updates.

Name(Required)